Growth Metrics

Novartis Ag (NVS) Gross Profit (2016 - 2025)

Novartis Ag's Gross Profit history spans 14 years, with the latest figure at $11.5 billion for Q2 2025.

  • On a quarterly basis, Gross Profit rose 18.71% to $11.5 billion in Q2 2025 year-over-year; TTM through Jun 2025 was $56.4 billion, a 98.88% decrease, with the full-year FY2025 number at $43.0 billion, up 10.49% from a year prior.
  • Gross Profit hit $11.5 billion in Q2 2025 for Novartis Ag, down from $18.7 billion in the prior quarter.
  • Over the last five years, Gross Profit for NVS hit a ceiling of $5000.0 billion in Q1 2023 and a floor of -$34.0 million in Q2 2022.
  • Historically, Gross Profit has averaged $435.3 billion across 5 years, with a median of $10.6 billion in 2024.
  • Biggest five-year swings in Gross Profit: crashed 143.04% in 2022 and later surged 14705782.35% in 2023.
  • Tracing NVS's Gross Profit over 5 years: stood at $14.0 million in 2021, then soared by 130557.14% to $18.3 billion in 2022, then dropped by 10.02% to $16.5 billion in 2023, then rose by 13.76% to $18.7 billion in 2024, then crashed by 38.5% to $11.5 billion in 2025.
  • Business Quant data shows Gross Profit for NVS at $11.5 billion in Q2 2025, $18.7 billion in Q4 2024, and $9.7 billion in Q2 2024.